The anti androgenic activity of r 2956 17 beta hydroxy 2 2 17 tri methyl estra 4 9 11 trien 3 one part 1 endocrinological profile
Azadian Boulanger, G.; Bonne, C.; Secchi, J.; Raynaud J P.
Journal de Pharmacologie 5(4): 509-520
1974
ISSN/ISBN: 0021-793X Document Number: 494155
Document emailed within 1 workday
Related Documents
Saksena, S.K.; Chaudhury, R.R. 1970: Androgenic, anti-androgenic and anabolic activity of azasteroids on immature castrated rats Indian Journal of Medical Research 58(4): 513-518Köhler, G.; Göretzlehner, G.; Rudolf, K.; Rüting, M.; Meissner, J.; Kunkel, S.; Schollberg, K. 1984: The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive Experimental and Clinical Endocrinology 84(3): 299-304
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569
Schubert, G.; Menzer, E.; Undeutsch, B. 2000: The synthesis of 4-(17 beta-methoxy-17 alpha-(methoxymethyl)-estra-4,-dien-11 beta-yl)benzaldehyd-1(e)-oxime Die Pharmazie 55(6): 463-464
Verimer, T.; Long, J.P.; Bhatnagar, R.K.; Koble, D.L.; Cannon, J.G.; Flynn, J.R.; Goodale, D.B.; Arnerić, S.P. 1981: Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives Archives Internationales de Pharmacodynamie et de Therapie 250(2): 221-241
Kirubagaran, R.; Joy, K.P. 1988: Inhibition of testicular 3 beta-hydroxy-delta 5-steroid dehydrogenase (3 beta-HSD) activity in catfish Clarias batrachus (L.) by mercurials Indian Journal of Experimental Biology 26(11): 907-908
Kotyla, P.ła.J. 2014: Pleiotropic activity of 3-hydroxy-3-methyl-glutharyl-coenzyme a inhibitors (statins). therapeutic potential in connective tissue diseases Annales Academiae Medicae Stetinensis 60(1): 39-45; Discussion: 45-46
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Laubie, M.; Cheymol, G.; Mouillé, P.; Gilbert, J.C.; Schmitt, H. 1973: Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395) Archives Internationales de Pharmacodynamie et de Therapie 201(2): 323-333
Dhar, S.K.; Mattu, S. 1995: Anti-implantation activity of 2 derivatives of o-hydroxy naphthaquinones in rats Zhongguo Yao Li Xue Bao 16(5): 471-472
Lutsky, B.N.; Millonig, R.C.; Wojnar, R.J.; Free, C.A.; Devlin, R.G.; Varma, R.K.; Karanewsky, D.S. 1986: Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activity Arzneimittel-Forschung 36(12): 1787-1795
Drexel, H. 1995: Activity profile of beta blockers Praxis 84(10): 278-280
Ma, X.; Yin, X.; Liu, H.; Chen, Q.; Feng, Y.; Ma, X.; Liu, W. 2019: Antiproliferative activity of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) in human gastric carcinoma cells is facilitated via activation of autophagic pathway, mitochondrial-mediated programmed cell death and inhibition of cell migration and invasion Journal of BUON: Official Journal of the Balkan Union of Oncology 24(5): 2000-2005
Mo, Z.; Jiao, X.; Su, H.; Zheng, H.; Weng, L. 1998: The estrogenic activities of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline(XW630)--a new compound with anti-osteoporosis activity Yao Xue Xue Bao 33(9): 645-649
Wojnar, R.J.; Alpaugh, W.C.; Dzelzkalns, E. 1985: Characterization of the anti-inflammatory activity and reduced potential for dermal atrophy of (11 beta, 16 beta)-9-fluoro-1',2',3', 4'-tetrahydro-11,21-dihydroxypregna-1,4-dieno[16,17-b]naph thalene-3, 20-dione hydrate (1 : 1) (SQ 26,490), a topically active corticoid Arzneimittel-Forschung 35(8): 1264-1268
Vermorken, A.J.; Sultan, C.; Goos, C.M. 1987: Dydrogesterone has no peripheral (anti)-androgenic properties In Vivo 1(3): 167-171
Goldfarb, S.; Pitot, H.C. 1971: The regulation of beta-hydroxy-beta-methylglutaryl coenzyme a reductase in Morris hepatomas 5123C, 7800, and 9618A Cancer Research 31(12): 1879-1882
O'Connor, D.M.; Crowe, M.J. 2003: Effects of beta-hydroxy-beta-methylbutyrate and creatine monohydrate supplementation on the aerobic and anaerobic capacity of highly trained athletes Journal of Sports Medicine and Physical Fitness 43(1): 64-68
Koble, D.L.; Koons, J.C.; Fischer, L.J. 1985: Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(3): 305-311
Parrott, R.F. 1974: Effects of 17 beta-hydroxy-4-androsten-19-ol-3-one (19-hydroxytestosterone) and 5 alpha-androstan-17-beta-ol-3-one (dihydrotestosterone) on aspects of sexual behaviour in castrated male rats Journal of Endocrinology 61(1): 105-115